EN
NL
FR
PT
Primary links Portuguese
EMPRESA
NOTICIA
CORPORATE
PRODUCTS
R&D
LOCAL NETWORK
PARTNERS
CSRP
CAREERS
NEWS
Home
Press release
Preview
Attachment
Size
Comparison of Different Artemisinin-based Combinations for the Treatment of Children.pdf
204.11 KB
Efficacy and safety of a fixed dose AS SMP compared to AL a randomized multi-centre study.pdf
274.73 KB
Efficacy of Artesunate + Sulfamethoxypyrazine-Pyrimethamine vs Praziquantel.pdf
246.4 KB
Artemether lumefantrine suspension vs artemether lumefantrine tablets.pdf
388.89 KB
Single-day, three-dose treatment with fixed dose combination AS SMP to cure Plasmodium falciparum malaria.pdf
640.38 KB
Assessment of the therapeutic efficacy of a paediatric formulation of AL (Coartesiane®) for the treatment of uncomplicated Plasmodium falciparum in children in Zambia.pdf
225.77 KB
Efficacy of AL (Co-Artesiane®) suspension in the treatment of uncomplicated Plasmodium falciparum malaria among children under 5 in eastern Sudan.pdf
106.5 KB
Rectal artemether versus intravenous quinine for the treatment of cerebral malaria in children in Uganda: randomised clinical trial.pdf
96.92 KB
A randomized trial of AS SMP versus AL for the treatment of uncomplicated plasmodium falciparum malaria in Mali.pdf
240 KB
Nederlands
Français
Português
Press release
Secondary links
NOTICIA
Rede local
Towards the eradication of malaria
PRODUCTS
ANALGESICS
ANTIBIOTICS
ANTIFUNGAL
ANTIHISTAMINICS
ANTI INFECTIVES
CARDIOVASCULAR
GASTRO INTESTINAL
HORMONAL
OTHERS
R&D
ONCOLOGY
GLOBAL HEALTH
LOCAL NETWORK
MALI
KENYA
NIGERIA
NEWS
PRESS RELEASE
ARTICLES
Dafra Pharma International
Slachthuisstraat 30/7
B-2300
Turnhout
Belgium
Tel. +32 (0) 14 61 78 20
Fax. +32 (0) 14 61 78 59